Annovis Bio Releases Preclinical Data Showing Synergistic Effect of Buntanetap in Enhancing Cognition in Alzheimer’s Mouse Model
Annovis Bio releases preclinical data showing the synergistic effect of buntanetap in enhancing cognition in Alzheimer’s mouse model, indicating potential breakthrough in treatment.
This news matters as it highlights a potential breakthrough in Alzheimer’s disease treatment, with the combination of buntanetap and dulaglutide showing compelling results in restoring and enhancing cognitive function. The growing market for Alzheimer's therapeutics also signals the increasing need for innovative treatment options.
